PUOTI MASSIMO

Piselli, P., Tavelli, A., Cimaglia, C., Muccini, C., Bandera, A., Marchetti, G., et al. (2025). Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data. INTERNATIONAL JOURNAL OF CANCER, 157(6), 1142-1153 [10.1002/ijc.35493]. Detail

Caviglia, G., Dileo, E., Olivero, A., Mengozzi, G., Ciancio, A., Loglio, A., et al. (2025). The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm. LIVER INTERNATIONAL, 45(9) [10.1111/liv.70242]. Detail

Taramasso, L., Rossotti, R., Tavelli, A., Santoro, M., Mazzotta, V., Bandera, A., et al. (2025). Brief Report: New HIV Diagnoses in PrEP-Experienced and PrEP-Naive Persons in the ICONA Cohort. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 98(4), 352-356 [10.1097/QAI.0000000000003576]. Detail

Mussini, C., Giacomelli, A., Quiros-Roldan, E., Mazzotta, V., Di Biagio, A., De Vito, A., et al. (2025). Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation. ECLINICALMEDICINE, 86(August 2025) [10.1016/j.eclinm.2025.103368]. Detail

Gagliardini, R., De Benedittis, S., Tavelli, A., Lapadula, G., Mazzotta, V., Bruzzesi, E., et al. (2025). Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 80(8), 2169-2178 [10.1093/jac/dkaf184]. Detail